...
首页> 外文期刊>Internal medicine. >Clinical Features of Cirrhosis in Japanese Patients with Type I Autoimmune Hepatitis
【24h】

Clinical Features of Cirrhosis in Japanese Patients with Type I Autoimmune Hepatitis

机译:日本I型自身免疫性肝炎患者肝硬化的临床特征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective Autoimmune hepatitis (AIH) is a chronic inflammatory disorder of unknown etiology that may proceed to cirrhosis, although some patients already have cirrhosis at the time of AIH diagnosis. The aim of this study was to clarify the clinical characteristics of AIH patients with cirrhosis in Japan. Methods Questionnaires were sent to liver specialists at four research facilities. Data for 250 patients diagnosed with AIH using the scoring system of the International Autoimmune Hepatitis Group (IAIHG) between 1975 and 2010 were collected and analyzed. Results The male-to-female ratio was 1:8.3 and the average patient age was 55.6 years. Liver cirrhosis was found in 51 AIH patients (20.4%). Of these, 43 patients (84.3%) had cirrhosis at presentation and eight patients (15.7%) developed cirrhosis during the follow-up period (average follow-up of 82.1 months). There were significant differences between the two groups with and without cirrhosis at presentation with regard to age and biochemical parameters at presentation. There were no significant differences in histology, with the exception of liver fibrosis. The overall 10-year probability of survival was 71.2% vs. 99.3% in the patients with and without cirrhosis (log-rank test, p<0.001). The relapse rate was significantly higher in the patients who developed cirrhosis during treatment than in those who did not develop cirrhosis during treatment (100% vs. 7.5%, p<0.001). Conclusion Since liver cirrhosis has already developed at presentation in many AIH patients with cirrhosis, it is important to diagnose the disease in the early stage and administer treatment rapidly with corticosteroids or immunosuppressants. In addition, a history of relapse is a risk factor for the development of cirrhosis in Japanese patients with AIH.
机译:目的自身免疫性肝炎(AIH)是一种病因不明的慢性炎症性疾病,可能会发展为肝硬化,尽管某些患者在诊断AIH时已患有肝硬化。这项研究的目的是阐明日本AIH肝硬化患者的临床特征。方法将调查表发送给四个研究机构的肝脏专家。收集并分析了1975年至2010年之间使用国际自身免疫性肝炎小组(IAIHG)评分系统诊断为AIH的250例患者的数据。结果男女之比为1:8.3,平均患者年龄为55.6岁。 51例AIH患者中发现了肝硬化(20.4%)。其中,有43例(84.3%)表现为肝硬化,有8例(15.7%)在随访期间(平均随访82.1个月)发展为肝硬化。就年龄和生化指标而言,有和没有肝硬化的两组之间存在显着差异。除肝纤维化外,组织学无明显差异。肝硬化患者和非肝硬化患者的10年总生存率分别为71.2%和99.3%(对数秩检验,p <0.001)。在治疗过程中发展为肝硬化的患者的复发率明显高于在治疗过程中未发展为肝硬化的患者(100%vs. 7.5%,p <0.001)。结论由于许多AIH肝硬化患者已出现肝硬化,因此早期诊断该病并迅速应用糖皮质激素或免疫抑制剂治疗非常重要。此外,复发史是日本AIH患者发展为肝硬化的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号